637
Views
38
CrossRef citations to date
0
Altmetric
Original Research

Different Modulation of Decorin Production by Lung Fibroblasts from Patients with Mild and Severe Emphysema

, , , , , , & show all
Pages 17-25 | Published online: 24 Aug 2009
 

Abstract

We have previously reported diminished immunohistochemical staining of decorin in lung tissue from patients with severe emphysema. The aim of this study is to investigate whether this diminished staining is due to a quantitative abnormal production of decorin by pulmonary fibroblasts in vitro. Therefore, we measured decorin (Western blot), collagen type I (ELISA), and fibronectin (ELISA) production by fibroblasts obtained from lung tissue of patients with severe and mild emphysema at basal culture conditions and after modulation with transforming growth factor-β1, basic fibroblast growth factor, and interferon-γ. Decorin production at basal culture conditions was significantly higher in fibroblast cultures from patients with severe emphysema compared to fibroblasts from mild emphysema. After stimulation with transforming growth factor-β1 and basic fibroblast growth factor, decorin production was significantly more reduced in fibroblast cultures from patients with severe emphysema whereas collagen type I and fibronectin production were not affected. We conclude that decorin production by lung fibroblasts of patients with severe emphysema is dysregulated after modulation with cytokines known to be important in smoking associated inflammation. This dysregulation of decorin production may contribute to the impaired lung tissue repair, present in patients with emphysema, since these alterations in the extracellular matrix may cause diminished cytokine binding and neutralization.

Abbreviations
bFGF:=

basic fibroblast growth factor

ECM:=

extracellular matrix

FCS:=

fetal calf serum

FEV1:=

forced expiratory volume in 1 second

IFN-γ:=

interferon-γ

MMP:=

matrix metalloproteinases

PI:=

protease inhibitor

TGF-β1:=

transforming growth factor-β1

VC:=

vital capacity

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.